|
|
Article: /C O R R E C T I O N -- Par Pharmaceutical Companies, Inc./.
- Article from:
- PR Newswire
- Article date:
- May 22, 2006
CopyrightCOPYRIGHT 2006 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
In the news release, Patrick G. LePore Elected to Board of Directors of Par Pharmaceutical Companies, Inc., issued earlier today by Par Pharmaceutical Companies, Inc. over PR Newswire, we are advised by the company that the second sentence in the boilerplate should read "In 2005, Par received approval for and introduced Megace(R) ES, its first branded pharmaceutical product, and ...
Related newspaper, magazine, and journal articles:
|
|
Article: Pharmaceutical Resources, Inc. Renamed Par ...
PR Newswire;
May 26, 2004 ;
673 words
... ... change the name of the company to Par Pharmaceutical Companies, Inc. The name change will ... of shares of common stock in Par Pharmaceutical Companies, Inc. The shares of Par Pharmaceutical Companies, Inc.'s common stock will ...
|
|